Evidence map›Paper›PMID 38589832›Full record

ArticleBMC cancer2024

Predictive value of CT and

Haijun Li, Lifeng Li, Yumeng Liu, Yingke Deng, Yu Zhu, Ling Huang, Ting Long, Li Zeng, Yongqiang Shu, Dechang Peng

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Haijun Li *Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Lifeng Li *Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Yumeng LiuDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Yingke DengDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Yu ZhuDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Ling HuangDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Ting LongDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Li ZengDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China.
Yongqiang ShuPET Center, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China.
Dechang PengDepartment of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17 Yongwai Zheng Street, Donghu District, Nanchang City, 330006, Jiangxi Province, China. pengdcdoctor@163.com.
Nanchang University · CNFirst Affiliated Hospital of Jiangxi Medical College · CNChangsha Medical University · CN

Funding

Natural Science Foundation Project of Jiangxi No. 20202BABL216036
6 · The paper itself

Abstract

backgroundLung adenocarcinoma, a leading cause of cancer-related mortality, demands precise prognostic indicators for effective management. The presence of spread through air space (STAS) indicates adverse tumor behavior. However, comparative differences between

methodsBetween February 2022 and April 2023, 100 patients (108 lesions) who underwent surgery for clinical lung adenocarcinoma were enrolled. All these patients underwent

resultsSixty lesions were positive for STAS, and 48 lesions were negative for STAS. The STAS-positive was frequently observed in acinar predominant. However, STAS-negative was frequently observed in minimally invasive adenocarcinoma. Univariable analysis results revealed that CT features (including nodule type, maximum tumor diameter, maximum solid component diameter, consolidation tumor ratio, pleural indentation, lobulation, spiculation) and all

conclusionThe radiological features of SUVmax is the best model for predicting STAS in lung adenocarcinoma. These radiological features could predict STAS with excellent specificity but inferior sensitivity.

Indexed as

Adenocarcinoma of LungLung NeoplasmsFluorodeoxyglucose F18HumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesTomography, X-Ray ComputedFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTComputed tomographyLung adenocarcinomaSTASSurgery

Identifiers

PMID38589832
PMCPMC11003164
OpenAlexW4394568234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.